A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia

AstraZeneca

Status: Completed

Conditions: Schizophrenia

Study type: Observational

Funder types: Industry

Identifiers

NCT01212575

NIS-NDK-SER-2010/2

Details and patient eligibility

About

The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of outpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.

Enrollment: 186 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults with a diagnosis of schizophrenia from a district psychiatric clinic in Denmark
• Patients who have received at least one dose of Seroquel XR or Seroquel IR during January - March 2010

Exclusion criteria

• Patients already participating in a clinical study during the study-period.

Trial design

186 participants in 1 patient group

300 patients

Description:

Female or male aged 18-65 years with a diagnosis of schizophrenia having received at least one dose of Seroquel XR or Seroquel IR during January - March 2010